Mdm2-p53 signaling regulates epidermal stem cell senescence and premature aging phenotypes in mouse skin

Developmental Biology

Volumn 353, Issue 1, 2011, Pages 1-9

  Gannon, Hugh S ^a   Donehower, Lawrence A ^b   Lyle, Stephen ^a   Jones, Stephen N ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Aging; Epithelial stem cell; Mdm2; P53

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL AGING; CELL FUNCTION; CONTROLLED STUDY; EPIDERMAL STEM CELL; HAIR GROWTH; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SENESCENCE; SIGNAL TRANSDUCTION; SKIN EPITHELIUM; SKIN INJURY; STEM CELL; WOUND HEALING;

MUS;

EID: 79953747376     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2011.02.007     Document Type: Article

References (44)

1. Balasubramanian S., Ahmad N., Jeedigunta S., Mukhtar H. Alterations in cell cycle regulation in mouse skin tumors. Biochem. Biophys. Res. Commun. 1998, 243(3):744.
2. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell 2005, 120(4):513-522.
3. Chen J., Lin J., Levine A.J. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol. Med. 1995, 1(2):142-152.
4. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A., Butel J.S., Bradley A. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992, 356(6366):215-221.
5. Freedman D.A., Levine A.J. Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol. Cell. Biol. 1998, 18(12):7288-7293.
6. Flores I., Blasco M.A. A p53-dependent response limits epidermal stem cell functionality and organismal size in mice with short telomeres. PLoS ONE 2009, 4(3):e4934.
7. Garcia-Cao I., Garcia-Cao M., Martin-Caballero J., Criado L.M., Klatt P., Flores J.M., Weill J.C., Blasco M.A., Serrano M. "Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally. EMBO J. 2002, 21(22):6225-6235.
8. Gentry A., Venkatachalam S. Complicating the role of p53 in aging. Aging Cell 2005, 4(3):157-160.
9. Geyer R.K., Yu Z.K., Maki C.G. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2000, 2(9):569-573.
10. Grier J.D., Xiong S., Elizondo-Fraire A.C., Parant J.M., Lozano G. Tissue-specific differences of p53 inhibition by Mdm2 and Mdm4. Mol. Cell. Biol. 2006, 26(1):192-198.
11. Guo X., Keyes W.M., Papazoglu C., Zuber J., Li W., Lowe S.W., Vogel H., Mills A.A. TAp63 induces senescence and suppresses tumorigenesis in vivo. Nat. Cell Biol. 2009, 11(12):1451-1457.
12. Haupt Y., Maya R., Kazaz A., Oren M. Mdm2 promotes the rapid degradation of p53. Nature 1997, 387(6630):296-299.
13. Honda R., Tanaka H., Yasuda H. Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett. 1997, 420(1):25-27.
14. Itahana K., Mao H., Jin A., Itahana Y., Clegg H.V., Lindstrom M.S., Bhat K.P., Godfrey V.L., Evan G.I., Zhang Y. Targeted inactivation of Mdm2 RING finger E3 ubiquitin ligase activity in the mouse reveals mechanistic insights into p53 regulation. Cancer Cell 2007, 12:355-366.
15. Jenkins G. Molecular mechanisms of skin ageing. Mech. Ageing Dev. 2002, 123(7):801-810.
16. Jones S.N., Roe A.E., Donehower L.A., Bradley A. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 1995, 378(6553):206-208.
17. Kemp C.J., Wheldon T., Balmain A. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat. Genet. 1994, 8(1):66-69.
18. Kubbutat M.H., Jones S.N., Vousden K.H. Regulation of p53 stability by Mdm2. Nature 1997, 387(6630):299-303.
19. Lengner C.J., Steinman H.A., Gagnon J., Smith T.W., Henderson J.E., Kream B.E., Stein G.S., Lian J.B., Jones S.N. Osteoblast differentiation and skeletal development are regulated by Mdm2-p53 signaling. J. Cell Biol. 2006, 172(6):909-921.
20. Li M., Brooks C.L., Wu-Baer F., Chen D., Baer R., Gu W. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 2003, 302(5652):1972-1975.
21. Little N.A., Jochemsen A.G. Hdmx and Mdm2 can repress transcription activation by p53 but not by p63. Oncogene 2001, 20(33):4576-4580.
22. Liu Y., Lyle S., Yang Z., Cotsarelis G. Keratin 15 promoter targets putative epithelial stem cells in the hair follicle bulge. J. Invest. Dermatol. 2003, 121(5):963-968.
23. Maier B., Gluba W., Bernier B., Turner T., Mohammad K., Guise T., Sutherland A., Thorner M., Scrable H. Modulation of mammalian life span by the short isoform of p53. Genes Dev. 2004, 18(3):306-319.
24. Martins C.P., Brown-Swigart L., Evan G.I. Modeling the therapeutic efficacy of p53 restoration in tumors. Cell 2006, 127(7):1323-1334.
25. Mendrysa S.M., O'Leary K.A., McElwee M.K., Michalowski J., Eisenman R.N., Powell D.A., Perry M.E. Tumor suppression and normal aging in mice with constitutively high p53 activity. Genes Dev. 2006, 20(1):16-21.
26. Momand J., Zambetti G.P., Olson D.C., George D., Levine A.J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992, 69(7):1237-1245.
27. Montes de Oca Luna R., Wagner D.S., Lozano G. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 1995, 378(6553):203-206.
28. Morris R.J., Potten C.S. Highly persistent label-retaining cells in the hair follicles of mice and their fate following induction of anagen. J. Invest. Dermatol. 1999, 112(4):470-475.
29. Nowak J.A., Fuchs E. Isolation and culture of epithelial stem cells. Stem Cells in Regenerative Medicine: Methods and Protocols 2009, 482:215-232. Humana Press. J. Audet, W.L. Stanford (Eds.).
30. Poyurovsky M.V., Prives C. Unleashing the power of p53: lessons from mice and men. Genes Dev. 2006, 20(2):125-131.
31. Rhee H., Polak L., Fuchs E. Lhx2 maintains stem cell character in hair follicles. Science 2006, 312(5782):1946-1949.
32. Ressler S., Bartkova J., Niederegger H., Bartek J., Scharffetter-Kochanek K., Jansen-Durr P., Wlaschek M. p16INK4A is a robust in vivo biomarker of cellular aging in human skin. Aging Cell 2006, 5(5):379-389.
33. Rodier F., Campisi J., Bhaumik D. Two faces of p53: aging and tumor suppression. Nucleic Acids Res. 2007, 35(22):7475-7484.
34. Soussi T., Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat. Rev. Cancer 2001, 1(3):233-240.
35. Steinman H.A., Jones S.N. Generation of an Mdm2 conditional allele in mice. Genesis 2002, 32(2):142-144.
36. Stenn K.S., Paus R. Controls of hair follicle cycling. Physiol. Rev. 2001, 81(1):449-494.
37. Taylor G., Lehrer M.S., Jensen P.J., Sun T.T., Lavker R.M. Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell 2000, 102(4):451-461.
38. Tumbar T., Guasch G., Greco V., Blanpain C., Lowry W.E., Rendl M., Fuchs E. Defining the epithelial stem cell niche in skin. Science 2004, 303(5656):359-363.
39. Tyner S.D., Venkatachalam S., Choi J., Jones S., Ghebranious N., Igelmann H., Lu X., Soron G., Cooper B., Brayton C., Hee Park S., Thompson T., Karsenty G., Bradley A., Donehower L.A. p53 mutant mice that display early ageing-associated phenotypes. Nature 2002, 415(6867):45-53.
40. Vijg J., Hasty P. Aging and p53: getting it straight. A commentary on a recent paper by Gentry and Venkatachalam. Aging Cell 2005, 4(6):331-333.
41. Vousden K.H., Lu X. Live or let die: the cell's response to p53. Nat. Rev. Cancer 2002, 2(8):594-604.
42. Wang X., Arooz T., Siu W.Y., Chiu C.H., Lau A., Yamashita K., Poon R.Y. MDM2 and MDMX can interact differently with ARF and members of the p53 family. FEBS Lett. 2001, 490(3):202-208.
43. Xiong S., Van Pelt C.S., Elizondo-Fraire A.C., Liu G., Lozano G. Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development. Proc. Natl Acad. Sci. USA 2006, 103(9):3226-3231.
44. Zhou Z., Wang D., Wang X.J., Roop D.R. In utero activation of K5.CrePR1 induces gene deletion. Genesis 2002, 32(2):191-192.